
Synorga Pharmaceuticals Ltd
About Synorga Pharmaceuticals Ltd
Data last updated:
Synorga Pharmaceuticals Ltd is a public limited company based in Delhi, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 01 July 1981 and has been in existence for over 45 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230DL1981PLC011952. The company has 2 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Manmohan Singh Phull and Surinder Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 14/ 2 Ashok Nagar, New Delhi, Delhi, India – 110018.
As per the financials filed for FY 2017, the company reported a revenue of ₹18.9 Cr. For the same year it recorded a net profit of ₹2.91 Lakh (net margin 0.2%) and EBITDA of ₹4.42 Lakh (EBITDA margin 0.2%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Synorga Pharmaceuticals Ltd's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered Address14/ 2 Ashok Nagar, New Delhi, Delhi, India – 110018
- IndustryTrading, Wholesale, Other Wholesale
To see the full contact details of Synorga Pharmaceuticals Ltd, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Synorga Pharmaceuticals Ltd
FY 2025 filings availableSynorga Pharmaceuticals Ltd reported revenue of ₹18.9 Cr for FY 2017.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹18.9 Cr | ||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹4.42 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹2.91 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 0.2% | ||
| Net Profit Margin | 0.2% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Synorga Pharmaceuticals Ltd, buy the company report.
Board of directors of Synorga Pharmaceuticals Ltd
Synorga Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manmohan Singh Phull | Director | 30 Jan 2001 | 25 Years 9 Months | Current |
| Surinder Singh | Director | 30 Jan 2001 | 25 Years 9 Months | Current |
| Kultaran Singh Kochhar | Director | 01 Sep 1987 | 39 Years 2 Months | Current |
Auditor
Synorga Pharmaceuticals Ltd is audited by P.P.THUKRAL & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P.P.THUKRAL & CO. | FY 2017 | 000632N |
Shareholding
The shareholding of Synorga Pharmaceuticals Ltd is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Synorga Pharmaceuticals Ltd, buy the company report.
Legal cases
No court or tribunal cases involving Synorga Pharmaceuticals Ltd are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Synorga Pharmaceuticals Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Synorga Pharmaceuticals has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Synorga Pharmaceuticals Ltd, buy the company report.
Recent activity
Synorga Pharmaceuticals Ltd has 3 board changes on record since 1987: 3 appointments. The latest: Manmohan Singh Phull was appointed as Director on 30 Jan 2001.
Frequently asked questions
Synorga Pharmaceuticals is an active public limited company based in Delhi, India. The company works in wholesale, within the trading industry. It was incorporated on 01 July 1981 (45+ years old) and is registered under CIN U24230DL1981PLC011952.
Synorga Pharmaceuticals has 3 current directors:
- Manmohan Singh Phull - Director
- Surinder Singh - Director
- Kultaran Singh Kochhar - Director
The latest financial statements of Synorga Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Synorga Pharmaceuticals has 2 GST registrations on record and all of them are cancelled or inactive.
The CIN (Corporate Identification Number) of Synorga Pharmaceuticals is U24230DL1981PLC011952. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Synorga Pharmaceuticals was incorporated on 01 July 1981, making it 45+ years old. It is registered with the Registrar of Companies, Delhi.
Manmohan Singh Phull was appointed as Director on 30 Jan 2001. Surinder Singh was appointed as Director on 30 Jan 2001. Kultaran Singh Kochhar was appointed as Director on 01 Sep 1987.
The registered office of Synorga Pharmaceuticals is at 14 2 Ashok Nagar, New Delhi, Delhi, India – 110018.
Synorga Pharmaceuticals operates in the trading industry, in the wholesale segment.
The compliance status of Synorga Pharmaceuticals is compliant as of 01 July 2026. The company is actively filing with the Registrar of Companies.

